Home
About
Overview
Sharing Data
ORCID
Help
History (90)
Polycystic ovary syndrome.
Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry.
Angiogenesis inhibition in the treatment of lung cancer.
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
See All 90 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology. 2008 Jul 08; 71(2):136-44.
View in:
PubMed
subject areas
Adrenal Cortex Hormones
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Anti-Inflammatory Agents
Atrophy
Brain
Cladribine
Glatiramer Acetate
Humans
Immunoglobulins, Intravenous
Interferon-beta
Multiple Sclerosis
Natalizumab
Organ Size
Peptides
authors with profiles
Anthony T. Reder